Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19698 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Samantha A Hershenfeld und 20 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leukemia and Lymphoma Society of Canada, Hold 'em for Life Oncology Fellowship.
Abstract (Originalsprache)
Radiotherapy is routinely used for management of limited‐stage follicular lymphoma (FL), yet half of patients ultimately relapse. We hypothesized that the presence of specific gene mutations may predict outcomes. We performed targeted sequencing of a 69‐gene panel in 117 limited‐stage FL patients treated with radiotherapy and identified recurrently mutated genes. CREBBP was most frequently mutated, and mutated CREBBP was associated with inferior progression‐free survival, though not after false discovery rate adjustment. This association failed to validate in an independent cohort. We conclude that recurrent gene mutations do not predict outcomes in this setting. Alternative biomarkers may offer better prognostic insight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
- Mater Research University of Queensland, Brisbane, Queensland, Australia.
- Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- Department of Oncology, Oslo University Hospital, Oslo, Norway.
- Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Samantha A Hershenfeld, Josuha W D Tobin, Maja Ludvigsen, Michael Crump, John Kuruvilla, David C Hodgson, Robert Kridel
Förderung
- Leukemia and Lymphoma Society of Canada
- Hold 'em for Life Oncology Fellowship
Zitieren
APA
Hershenfeld, S. A., Tobin, J. W. D., Shelton, V., Calvente, L., Lajkosz, K., Liu, T., Brodtkorb, M., d'Amore, F. A., Ludvigsen, M., Baetz, T., LeBrun, D., Johnson, N., Crump, M., Hong, M., Kuruvilla, J., Tremblay-LeMay, R., MacManus, M., Tsang, R., Hodgson, D. C., …, & Kridel, R. (2024). Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.19698
Vancouver
Hershenfeld SA, Tobin JWD, Shelton V, Calvente L, Lajkosz K, Liu T, et al. Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy. British Journal of Haematology. 2024. doi:10.1111/bjh.19698
BibTeX
@article{Hershenfeld2024,
author = {Hershenfeld, Samantha A and Tobin, Josuha W D and Shelton, Victoria and Calvente, Lourdes and Lajkosz, Katherine and Liu, Ting and Brodtkorb, Marianne and d'Amore, Francesco Annibale and Ludvigsen, Maja and Baetz, Tara and LeBrun, David and Johnson, Nathalie and Crump, Michael and Hong, Michael and Kuruvilla, John and Tremblay-LeMay, Rosemarie and MacManus, Michael and Tsang, Richard and Hodgson, David C and Gandhi, Maher K and Kridel, Robert},
title = {Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19698}
}
EUVIMED